29 2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Air emissions Air emissions data can be found in the data tables within the appendices . 2030+ goals: Reduce volatile organic compounds (VOCs) and hazardous air pollutants (HAPs) by 30% by 2030 (from 2019 baseline, normalized to COPS) Reduce ozone-depleting substances (ODS) by 50% by 2030 (from 2019 baseline, normalized to COPS) Eliminate use of R22 by 2030 (absolute) Current status: Reduced by 32% We saw a reduction of around 100 metric tonnes in VOC emissions, due to the installation of additional abatement equipment following a transfer of product lines between two of our manufacturing locations. Reduced by 87% As part of ongoing programs, we achieved further reductions in ODS emissions at our BD Medical manufacturing facilities. A large proportion of the reduction was made in FY 2019 and FY 2020 through elimination projects at one of our manufacturing facilities. Two additional manufacturing facilities accounted for a significant proportion of the reduction in FY 2021. R22 refrigerant (also known as R22 freon and HCFC-22 freon) is a chemical used in both air conditioners and heat pumps. It has a harmful impact on the ozone layer when released into the air and therefore has been banned from manufacture or import in many jurisdictions where BD operates. Through FY 2021 and FY 2022, we are carrying out an audit of all our locations worldwide in order to capture the number and type of R22 units in use. For sites with multiple R22 units, we are working with external partners to conduct these studies. Using our Replace with a Purpose approach, site-level plans will be developed that focus on compliance, reliability, redundancy and long-term capacity while optimizing efficiency. By avoiding like-for-like replacements, our Replace with a Purpose approach will ensure that the long-term needs of our sites are met.